This clinical practice guideline includes statements and recommendations based on available, high-level evidence about the use of hypofractionated radiotherapy for the treatment of women with early (operable) breast cancer. The guideline aims to provide health professionals with information designed to assist in making management recommendations for patient outcomes. These guidelines will inform the development of information specifically for consumers about early breast cancer, including treatment options.
|File size:||162.58 KB|
|Cancer Type:||Breast cancer|
|Publication Audience:||Resources for health professionals|
This resource has been developed, reviewed or revised within the last 5 years.